Does Motive Matter In Anti-Bribery And Anti-Corruption Enforcement?

Published date07 November 2013
Law FirmThomas Fox
Subject MatterAnti-Bribery,Anti-Corruption,China,Compliance,Enforcement,Foreign Corporations,GlaxoSmithKline,Pharmaceutical Industry

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT